Journal Management System
ScopeMed is an
Online Journal/Article Management system
that can enable all of the operations of
the editorial functions of a journal.
Home  |   Add your Journal  |   Properties of ScopeMed  |   Video Tutorials  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  


Journal of Experimental and Integrative Medicine
Periodical of GESDAV
Journal Home Page
ISSN: 1309-4572 (Print)
ISSN: 2146-3298 (Online)
Language: [ English ]  

  » Volume 3, Issue 2
      pp. 81-169
  » Volume 3, Issue 1
      pp. 1-79

 

Open Access

Invited Review



Medical ozone is now ready for a scientific challenge: current status and future perspectives

Lamberto Re, Giuseppe Malcangi, Gregorio Martinez-Sanchez.

A B S T R A C TR E F E R E N C E SCited by (3) 

Abstract
The aim of the present review is to clarify some of the basic mechanisms underlying ozone therapy. Indeed, after its empiric use started at the beginning of the last century, science is now ready to give a chance to the more and more medical doctors working in this field. Unfortunately, the lack of a full recognition by the health authorities and some ostracism against it is, up to date, the major obstacle for its full medical acceptance. Anyway, in the last years and thanks to the contributions of several scientists, most of the mechanisms characterizing the bio-humoral activity of ozone have been scientifically outlined. The built up of randomized clinical studies is going on slowly despite the lack of funds and the difficulties bound mainly to the huge variability of the ozone action.
The thousand and thousand medical doctors involved in the use of ozone as emerging therapy, must be fully educated about the properties of this gas in the aim to counteract scientifically the criticisms of colleagues devoted to other field of medicine and not expert of the ozone pharmacological properties. Is for this reason that we encourage all the professionals to deeply increase the knowledge related to the scientific data produced and published on the international literatures in the field of the ozone therapy.
For the future we suggest the use of ozone not in alternative but as a complement of the most appropriate pharmacological treatments also in the aim to reduce some side effects derived from a chronic drug use. The lack of a well-defined binding site for the ozone molecule could suggest the introduction of virtual receptors for the supposed biological activity of ozone acting mostly throughout second messengers pathways.

Key words: Complementary therapy; Ozone; Ozone therapy


ARTICLE TOOLS
Abstract
PDF Fulltext
Email this Article
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Lamberto Re
Articles by Giuseppe Malcangi
Articles by Gregorio Martinez-Sanchez
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 490
Downloaded: 355
(Last 7 Days: 3)
Cited: 3
Emailed: 0

REFERENCES
1.Penner R, Neher E. The patch-clamp technique in the study of secretion. Trends Neurosci 1989; 12:159-63.
[DOI via Crossref]    [Pubmed]   

2.Re L, Cola V, Fulgenzi G, Marinelli F, Concettoni C, Rossini L. Postsynaptic effects of methoctramine at the mouse neuromuscular junction. Neuroscience 1993; 57:451-7.
[
DOI via Crossref]    [Pubmed]   

3.Re L, Moretti V, Rossini L, Giusti P. Sodium-activated potassium current in mouse diaphragm. FEBS Lett 1990; 270:195-7.
[
DOI via Crossref]    [Pubmed]   

4.Bhattacharjee A, Kaczmarek LK. For K+ channels, Na+ is the new Ca2+. Trends Neurosci 2005; 28:422-8.
[
DOI via Crossref]    [Pubmed]   

5.Bocci V. Ozone A New Medical Drug, Springer, Dordrecht, The Nederlands, p 295, 2005.

6.Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev 2009; 29:646-82.
[
DOI via Crossref]    [Pubmed]   

7.Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol 2008; 66:594-617.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

8.Martinez-Sanchez G, Perez-Davison G, Re L, Giuliani A. Ozone as U-shaped dose responses molecules (hormetins). Dose Response 2011; 9:32-49.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

9.Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med 2011; 9:66.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

10.Martinez Y, Guanche D, Zamora Z, Hernandez F, Alonso Y, Gonzalez Torres Y. Efecto de la mezcla ozono/oxígeno en el balance redox tisular en un estudio de toxicidad subcrónica en conejo. Retel 2009; 20:15-22.

11.Borrego A, Zamora ZB, Gonzalez R, Romay C, Menendez S, Hernandez F, Montero T, Rojas E. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm 2004; 13:13-9.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

12.Kesik V, Uysal B, Kurt B, Kismet E, Koseoglu V. Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biol Ther 2009; 8:1623-8.
[
DOI via Crossref]    [Pubmed]   

13.Demirbag S, Uysal B, Guven A, Cayci T, Ozler M, Ozcan A, Kaldirim U, Surer I, Korkmaz A. Effects of medical ozone therapy on acetaminophen-induced nephrotoxicity in rats. Ren Fail 2010; 32:493-7.
[
DOI via Crossref]    [Pubmed]   

14.Paoloni M, Di Sante L, Cacchio A, Apuzzo D, Marotta S, Razzano M, Franzini M, Santilli V. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976) 2009; 34:1337-44.
[
DOI via Crossref]    [Pubmed]   

15.Steppan J, Meaders T, Muto M, Murphy KJ. A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J Vasc Interv Radiol 2010; 21:534-48.
[
DOI via Crossref]    [Pubmed]   

16.Magalhaes FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET. Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician,2012; 15:E115-29.
[
Pubmed]   

17.Belianin II. Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid. Zh Mikrobiol Epidemiol Immunobiol 2004; 3:95-8.
[
Pubmed]   

18.Belianin II, Martynova LP, Shmelev EI. Dissolved ozone treatment-induced change in the resistance of multi-resistant mycobacterial strain to isoniazid and rifampicin. Probl Tuberk 2002; 1:46-9.
[
Pubmed]   

19.McFadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol 2002; 135:1-13.
[
DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   

20.Bocci V, Valacchi G, Rossi R, Giustarini D, Paccagnini E, Pucci AM, Di Simplicio P. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 1999; 10:110-6.
[
Pubmed]   

This Article Cited By the following articles

2013: Starting a new publication year and new volume with a new issue of our young but promising Journal
Journal of Experimental and Integrative Medicine 2013; 3(1): 1.

1
 
Ozone Oxidative Preconditioning Prevents Atherosclerosis Development in New Zealand White Rabbits
Journal of Cardiovascular Pharmacology 2013; 61(2): 160-165.

2
 
Are we ready for a medical ozone challenge
Journal of Experimental and Integrative Medicine 2012; 2(3): 189.

3
 

How to Cite this Article
Pubmed Style

Re L, Malcangi G, Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: current status and future perspectives. J Exp Integr Med. 2012; 2(3): 193-196. doi:10.5455/jeim.070612.ir.012



Web Style

Re L, Malcangi G, Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: current status and future perspectives. www.scopemed.org/?mno=18540 [Access: May 24, 2013]. doi:10.5455/jeim.070612.ir.012



AMA (American Medical Association) Style

Re L, Malcangi G, Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: current status and future perspectives. J Exp Integr Med. 2012; 2(3): 193-196. doi:10.5455/jeim.070612.ir.012



Vancouver/ICMJE Style

Re L, Malcangi G, Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: current status and future perspectives. J Exp Integr Med. (2012), [cited May 24, 2013]; 2(3): 193-196. doi:10.5455/jeim.070612.ir.012



Harvard Style

Re, L., Malcangi, G. & Martinez-Sanchez, G. (2012) Medical ozone is now ready for a scientific challenge: current status and future perspectives. J Exp Integr Med, 2 (3), 193-196. doi:10.5455/jeim.070612.ir.012



Turabian Style

Re, Lamberto, Giuseppe Malcangi, and Gregorio Martinez-Sanchez. 2012. Medical ozone is now ready for a scientific challenge: current status and future perspectives. Journal of Experimental and Integrative Medicine, 2 (3), 193-196. doi:10.5455/jeim.070612.ir.012



Chicago Style

Re, Lamberto, Giuseppe Malcangi, and Gregorio Martinez-Sanchez. "Medical ozone is now ready for a scientific challenge: current status and future perspectives." Journal of Experimental and Integrative Medicine 2 (2012), 193-196. doi:10.5455/jeim.070612.ir.012



MLA (The Modern Language Association) Style

Re, Lamberto, Giuseppe Malcangi, and Gregorio Martinez-Sanchez. "Medical ozone is now ready for a scientific challenge: current status and future perspectives." Journal of Experimental and Integrative Medicine 2.3 (2012), 193-196. Print. doi:10.5455/jeim.070612.ir.012



APA (American Psychological Association) Style

Re, L., Malcangi, G. & Martinez-Sanchez, G. (2012) Medical ozone is now ready for a scientific challenge: current status and future perspectives. Journal of Experimental and Integrative Medicine, 2 (3), 193-196. doi:10.5455/jeim.070612.ir.012




» Last Downloads

Please Wait...




Total Download: 36.119
(for Journal of Experimental and Integrative Medicine)
Total Submission during last 24 hours: 148


» For Authors




Become Reviewer


» Login Area




Follow ScopeMed on Twitter

ScopeMed Home | About ScopeMed | Contact Us | Terms & Conditions | Privacy Policy
The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGE Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.